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The present study was designed to determine the apparent absorption and retention of the
inorganic Se compounds SeO3
22 and SeO4
22, which are commonly used for Se fortification of
clinical nutrition products and infant formulas. Ten healthy men were fed a milk-based formula
labelled with 40 mg Se as 74SeO3
22 or 76SeO4
22 on two consecutive days using a randomised
crossover design. Se stable-isotope analysis of 9 d complete collections of urine and faeces was
used to calculate apparent Se absorption and retention. Se retention from 74SeO3
22 (41·0 (SD
8·4) %) and from 76SeO4
22 (46·0 (SD 7·9) %) was not significantly different P . 0·05:
However, Se absorption was significantly higher from SeO4
22 than from SeO3
22 (91·3 (SD 1·4)
% v. 50·2 (SD 7·8) %, P , 0·05: Urinary excretion of the administered dose was 9·2 (SD 1·8) %
for 74SeO3
22 and 45·3 (SD 8·2) % for 76SeO4
22 P , 0·05: Urinary Se excretion kinetics
differed significantly for the two Se compounds; 90 % of the total urinary Se was excreted after
121 h for 74SeO3
22 and after 40 h for 76SeO4
22 P , 0·05: These results suggest that although
Se absorption and urinary excretion differ for SeO3
22 and SeO4
22, both Se compounds are
equally well retained when administered at a relatively low dose (40 mg Se). The nutritional
impact of Se fortification of foods would thus be expected to be similar when SeO4
22 or SeO3
22
are used.
Selenium fortification: Selenium absorption: Selenium retention: Inorganic selenium
compounds: Stable isotopes
Se is an essential trace element for human subjects
(National Research Council, 1989). Se is an integral part
of glutathione peroxidase (GSH-Px), an enzyme involved
in cellular protection against oxidative damage, and of
iodothyronine deiodinase which catalyses the conversion of
thyroxine into triiodothyronine (Zachara, 1993). Several
other selenoproteins, such as selenoprotein P, have been
isolated, but their physiological role is still not fully
elucidated (Zachara, 1993). In addition, Se has been
reported to play a role in the maintenance of optimal
immune response (Chandra, 1997), and the role of Se in the
emergence of viral mutations has been documented (Beck,
1996). Recently, the impact of Se supplementation on the
incidence of certain cancers (Clark et al. 1996) was
reported.
Low dietary Se intake has been associated with a number
of deficiency symptoms, of which Keshan disease, a fatal
cardiomyopathy endemic to low-Se areas in China, is the
most extensively documented (Lockitch, 1989). Popula-
tions at risk of impaired Se status are patients on long-term
parenteral or enteral nutrition without Se supplementation
(Levander, 1984) and infants consuming infant formulas
with a low Se content (Litov & Combs, 1991). Although no
overt clinical symptoms of Se deficiency have been
diagnosed in these individuals, cases of cardiac and
muscular dystrophies have been reported in patients on
long-term total parenteral nutrition (Casey & Hambidge,
1985; Hambidge, 1985; Vinton et al. 1987; Kelly et al.
1988).
Food fortification with Se is not widely used, except for
clinical products such as enteral and parenteral nutrition
products and infant formulas. Inorganic Se compounds,
SeO3
22 or SeO4
22, are typically used for food fortification
and information about bioavailability, absorption and
retention of these Se compounds in human subjects is
needed to estimate the nutritional impact of Se fortification.
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Previous studies of Se bioavailability have focused mainly
on the comparison between inorganic Se, in particular
SeO3
22, and organic Se compounds, selenomethionine or
Se-rich yeast (Alfthan et al. 1991; Xia et al. 1992; Ne`ve,
1995). Only very limited data on Se bioavailability from
inorganic compounds (SeO3
22 and SeO4
22) are available.
Furthermore, until now, no information about Se absorption
and retention from SeO3
22 and SeO4
22 after intake of
relatively small amounts of the Se compounds, relevant to
food fortification, has been reported. The recent develop-
ment of stable-isotope techniques offers the possibility of
monitoring absorption and retention of trace elements
without introducing radiation exposure (Sandstro¨m et al.
1993).
The aim of the present study was to compare apparent Se
absorption and retention from SeO3
22 and SeO4
22 in men
using a stable-isotope technique. The inorganic Se
compounds were added to a milk-based formula in
quantities relevant to food fortification. A milk-based
formula was selected as the food vehicle since it represents
the most common products fortified with Se (i.e. products
used for enteral nutrition or infant formulas).
Materials and methods
Subjects
Ten healthy men, 24–36 (mean 30) years old, were
recruited from personnel at the Nestle´ Research Centre,
Lausanne, Switzerland. The aims and procedures of the
study were explained verbally and in writing before
enrolment in the study. All subjects gave written informed
consent. A medical examination was carried out before
enrolment. Medication, dietary supplements and high-Se
food items (i.e. offal meat, fish and other seafoods) were
excluded during the study. In all other respects subjects
maintained their normal lifestyle and dietary habits during
the study. None of the subjects consumed dietary supple-
ments containing Se.
The study protocol was reviewed and approved by the
external ethical committee of the Nestle´ Research Centre
and followed the guidelines of the Helsinki Declaration
regarding human subjects.
Stable isotope labels
Highly-enriched elemental 74Se (74Se 98·2 %, 76Se 1·8 %,
other Se isotopes ,0·1 %), 76Se (74Se 1·2 %, 76Se 98·5 %,
77Se 0·2 %, other Se isotopes ,0·03 %) and 82Se (74Se
0·06 %, 76Se 0·62 %, 77Se 0·56 %, 78Se 1·76 %, 80Se
4·8 %, 82Se 92·2 %) were purchased from Isotec (St.
Quentin, France). Elemental Se was converted into
74SeO3
22, 76SeO4
22 and 82SeO3
22. SeO3
22 was prepared
by dissolving a precise amount of elemental Se (approxi-
mately 2·5–10 mg; weighed on a high-precision analytical
balance) into 1 ml concentrated HNO3. The solution was
heated for 1 h at 608C under N2. The clear solution
(approximately 0·2 ml) was made up to 20 ml with
deionised water, filtred through a 0·22 mm Teflon filter
and stored at 48C. SeO4
22 labels were prepared from the
SeO3
22 solution after evaporation to dryness at 1008C
under N2. H2O2 (5 ml) was added to the white precipitate to
oxidise SeO3
22. The solution was gently heated to 708C
and 0·2 ml KOH (2 mol/l) was added. The volume was
reduced under N2 to about 1 ml at 708C and the oxidation
step repeated three times. The solution was evaporated to
dryness, the white precipitate redissolved in deionised
water and 0·1 ml concentrated HNO3 was added. Finally,
the solution was made up to 20 ml, filtered through a
0·22 mm Teflon filter and stored at 48C.
Speciation of SeO3
22 and SeO4
22 stable-isotope solu-
tions was performed by continuous-flow hydride-genera-
tion atomic absorption spectrometry (HGAAS) based on
the principle that only SeO3
22, but not SeO4
22, can be
directly measured by HGAAS on reaction with a NaBH4
reductant solution (Van Dael et al. 1995). Determination of
SeO4
22 by HGAAS requires an HCl reduction step before
HGAAS analysis.
Se concentration of the stable-isotope solutions was
verified by continuous-flow HGAAS (Van Dael et al.
1995). For each isotope, stock solutions of 100 mg Se/ml in
HNO3 (0·01 mol/l) were prepared.
Test meals
A commercial ready-to-feed milk-based formula was used
as the test meal (Carnation Follow-Upw; Carnation, Glen-
dale, CA, USA). The product contained (g/l): protein 32·5,
fat 26·6, carbohydrate 85·6. Each test meal was prepared by
the addition of 40 mg Se as 74SeO3
22 or 76SeO4
22 to 500 g
formula. Test meals were prepared 15 h before adminis-
tration and stored at 48C until consumed.
Study design
A randomised crossover design was employed. Labelled
test meals (74SeO3
22- or 76SeO4
22-fortified formula) were
administered after an overnight fast on two consecutive
days. No food or drink was allowed for 3 h following
intake of the labelled test meals. Complete collection of
faeces and urine were made for 10 d, starting immediately
after intake of the first test meal. Individual portions of
faeces were collected in acid-washed plastic containers.
Urine was collected in acid-washed plastic bottles in 4 h
portions during the first 4 d followed by 24 h collections
for the remaining period of the study. A baseline 24 h urine
sample was collected the day preceding the study. All
excreta were labelled with the subject’s code, date and hour
of collection and immediately frozen at 2408C. Faecal
material was freeze-dried and homogenised using acid-
washed mortars and pestles. A faecal marker, 100 mg
Brilliant blue, was used to determine the start of the faecal
monitoring. A gelatine capsule containing the dye was
ingested on the evening before intake of the first test meal.
All individual faecal and urine samples (4 h and 24 h
collections) were analysed for total Se content and Se
isotopic ratios.
A venous blood sample (20 ml) was drawn after an
overnight fast into heparinised tubes for assessment of Se
status. Plasma and erythrocytes were separated by cen-
trifugation (2000 g at 48C for 15 min). Erythrocytes were
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washed twice with saline (0·9 g NaCl/l). Plasma and
erythrocyte samples were stored at 2808C until analysed.
Analytical methods
Total Se and stable-isotope ratios in samples of faeces and
urine were determined after acid digestion and derivatisa-
tion by GC–MS (Van Dael et al. 1998). Briefly, samples of
urine and faeces were acid-digested using a mixture of
HNO3–HClO4 (3:1, v/v) followed by the addition of HCl to
convert all Se to SeO3
22, which was then derivatised with
4-nitro-phenylene-diamine to form the volatile piazselenole
before the analysis by GC–MS. Total Se in the faecal and
urine samples was determined by isotope-dilution GC–MS
using 82SeO3
22 as a spike. The Se analysis was validated
against the standard reference material NIST 2670 toxic
metals in freeze-dried urine (National Institute of Standards
and Technology, Gaithersburg, MD, USA).
Total Se in the milk-based formula was determined by
continuous-flow HGAAS (Van Dael et al. 1995) and
validated against standard reference material NIST 1549
non-fat milk powder (National Institute of Standards and
Technology).
Plasma and erythrocyte Se levels were determined by
continuous-flow HGAAS (Van Dael et al. 1995) and
expressed as mg Se/l and mg Se/g haemoglobin (Hb)
respectively. The analysis was validated against a com-
mercial whole-blood and serum quality-control material
(Seronorm trace elements whole-blood batch no. 030016
and serum batch no. 010017; Nycomed, Oslo, Norway). Hb
was analysed by the cyanomethaemoglobin technique
(Makarem, 1974).
Plasma and erythrocyte GSH-Px activities were deter-
mined according to Belsten & Wright (1995) and expressed
per mg protein and per g Hb respectively. Plasma protein
concentrations were determined using a colorimetric
method (Pierce BCA, Rockford, IL, USA).
Apparent selenium absorption and retention
Apparent Se absorption and retention were calculated
according to Turnlund et al. (1993). Apparent absorption of
74Se and 76Se was calculated as the difference between the
administered dose and the total amount of stable isotopes
excreted in faeces. All faecal material collected from the
appearance of the faecal marker in the stools until day 9
after administration of the 74Se and 76Se isotope labels was
included in the calculation of apparent 74Se and 76Se
absorption respectively. Apparent Se retention was based
on apparent absorption and adjusted for the amount of 74Se
and 76Se excreted in urine collected over 9 d following the
administration of the specific isotope.
In addition, cumulative apparent Se absorption was
calculated based on the faecal excretion during consecutive
24 h faecal collections (i.e. 24 h, 48 h, 72 h etc.) after
administration of the labelled test meals. Similarly,
cumulative urinary Se excretion was calculated based on
consecutive 24 h urinary collections. Se retention of the
stable-isotope doses was calculated as the difference
between the cumulative excretion of 74Se and 76Se in
faeces and urine.
Statistical evaluation
Differences in Se absorption, retention and urinary
excretion between SeO3
22 and SeO4
22 were evaluated
using the t test procedure for crossover studies according to
Hills & Armitage (1979). Results are expressed as means
and standard deviations, and statistical significance is
defined as P , 0·05:
Results
Plasma Se concentration was 81·5 (SD 14·4; range 60·5–
104·0) mg Se/l, erythrocyte Se was 0·304 (SD 0·047; range
0·248–0·385) mg Se/g Hb, plasma GSH-Px was 6·4 (SD 0·8;
range 5·3–7·7) units/g protein and erythrocyte GSH-Px
activity was 52·4 (SD 6·6; range 41·9–62·8) units/g Hb.
Baseline urine Se concentration was 27·8 (SD 7·5; range
15·7–36·4) mg Se/l and 24 h urinary Se excretion was 32·1
(SD 6·1; range 23·8–39·4) mg Se. The Se level of the milk-
based formula was 12·6 (SD 0·4) mg Se/l (6·0 mg Se/500 g
formula). At least 97·5 % of the elemental stable-isotope
labels were transformed into 74SeO3
22, 76SeO4
22 and
82SeO3
22.
Apparent Se retention from 74SeO3
22 (41·0 (SD 8·4 %;
range 21·9–52·4) %) and 76SeO4
22 (46·0 (SD 7·9; range
33·3–56·1) %) was not significantly different. However,
apparent Se absorption and urinary excretion from the two
Se compounds differed considerably. Se absorption was
significantly P , 0·05 higher from SeO422 (91·3 (SD 1·4;
range 89·5–93·4) %) than from SeO3
22 (50·2 (SD 7·8; range
31·9–59·2) %). Urinary excretion of the administered dose
represented 9·2 (SD 1·8) % 74SeO3
22 and 45·3 (SD 8·2) %
76SeO4
22, corresponding to 18 and 50 % Se absorbed from
SeO3
22 and SeO4
22 respectively.
Cumulative faecal Se excretion (Fig. 1) differed
significantly P , 0·05 between the two Se compounds;
90 % of the total faecal Se (74Se and 76Se) was excreted
after 152 (SD 18) h and 65 (SD 21) h for 76SeO4
22 and
74SeO22 respectively. The corresponding times for 95 %
excretion were 177 (SD 14) h and 99 (SD 21) h for 76SeO4
22
and 74SeO3
22 respectively P , 0·05: Cumulative urinary
Se excretion (Fig. 2) also differed significantly P , 0·05
between the two Se compounds; 90 % of the total urinary
Se (74Se and 76Se) was excreted after 40 (SD 30) and 121
(SD 51) h for 76SeO4
22 and 74SeO3
22 respectively. The
corresponding times for 95 % excretion were 84 (SD 52)
and 144 (SD 55) h for 76SeO4
22 and 74SeO3
22 respectively
P , 0·05: Under the present experimental conditions,
apparent Se retention based on cumulative faecal and
urinary excretion of 74Se and 76Se showed that Se retention
was not significantly different between SeO3
22 and SeO4
22
P . 0·05 based on 120 h (74SeO322 44·7 (SD 8·0) %,
76SeO4
22 50·0 (SD 7·2) %) or 168 h (74SeO3
22 42·3 (SD
8·2) %, 76SeO4
22 47·6 (SD 7·6) %). Apparent Se retention
based on 120 or 168 h cumulative faecal and urinary
excretion did not differ significantly from data based on 9 d
collections P . 0·05:
No effect of the order of administration of labelled test
meals was detected for Se absorption, urinary excretion or
retention. For 74SeO3
22 Se retention was positively
correlated with absorption (r 0·98, P , 0·05; whereas for
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76SeO4
22 Se retention and urinary excretion were nega-
tively correlated (r 20·99, P , 0·05:
Discussion
The present study demonstrated that in men, mean apparent
Se retention was similar for SeO3
22 and SeO4
22 added to a
milk-based infant formula (41 % v. 46 %), although large
differences in absorption and urinary excretion were found.
The study design and the dose of 40 mg Se for each isotope
were based on nutritional considerations. Preliminary
analytical data showed that accurate Se stable-isotope
measurements in urine and faeces were possible after intake
of 40 mg Se and demonstrated the analytical feasability of
the study (Van Dael et al. 1998). The labelled test meals
were administered in a crossover design on two consecutive
days. A milk-based formula was selected as the test meal
because milk is the most common raw material for dietetic
foods such as enteral nutrition products or infant formulas.
These milk-based formulas, often the only dietary source of
energy and nutrients, are naturally low in Se and often
fortified with Se in order to meet dietary Se requirements.
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Fig. 1. Cumulative faecal selenium (74Se and 76Se) excretion by healthy men
after a single oral dose of 40 mg selenium as 74SeO3
22 (K) or 76SeO4
22 (W)
added to a milk-based formula. Values are means with their standard errors
represented by vertical bars for ten subjects. For details of experimental
procedures, see p. 159.
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Fig. 2. Cumulative urinary selenium (74Se and 76Se) excretion by healthy
men after a single oral dose of 40 mg selenium as 74SeO3
22 (K) or
76SeO4
22 (W) added to a milk-based formula. Values are means with their
standard errors represented by vertical bars for ten subjects. For details of
experimental procedures, see p. 159.
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Thus, information about Se retention and absorption from
these products at relevant fortification levels is needed. The
daily Se intake in Switzerland is estimated to be 60–70 mg
Se/d (Pfannhauser, 1994). The administration of 40 mg Se
as SeO3
22 or SeO4
22 on two consecutive days increased
the total dietary Se intake of the subjects to levels
comparable with the upper range of Se intakes in Europe
(van Dokkum, 1995). Previous data on Se retention and
absorption were based on Se doses ranging up to 200 mg Se
(i.e. considerably higher than the daily dietary Se intake in
most countries). Our data are therefore more relevant to Se
retention and absorption from Se-fortified foods within the
range of habitual dietary Se intakes in Europe. The subjects
in the present study were healthy European men with
adequate Se status, as judged from blood Se status
indicators and 24 h urinary Se excretion (Robberecht &
Deelstra, 1984; Van Dael & Deelstra, 1993). Se retention
data for SeO3
22 and SeO4
22 found in the present study are
in agreement with those of Thomson & Robinson (1986),
who reported Se retention from a 1000 mg dietary Se
supplement in New Zealand adults using a chemical-
balance technique (mean retention (%) SeO3
22 40, SeO4
22
32). Percentage Se retention was comparable with that
found in the present study despite the much higher doses of
Se administered. Our data on Se retention from the test
meal labelled with SeO3
22 are within the wide range of
reported results (30–75 %) based on stable-isotope techni-
ques (Christensen et al. 1983; Sirichakwal et al. 1985;
Martin et al. 1989; Mangels et al. 1990; Finley, 1999). The
reasons for the wide range in SeO3
22 retention values are
not known, although it can be assumed that factors such as
differences in study design, stable-isotope dose, dietary
regimen and normal Se intake may play a role.
Previous Se retention studies differed considerably in the
number of days (5–21) used in the faecal and urinary
collection period (Christensen et al. 1983; Sirichakwal et al.
1985; Martin et al. 1989; Mangels et al. 1990; Finley,
1999). Our data indicate that Se retention for SeO3
22 and
SeO4
22 based on 120 h collections of faeces and urine was
not significantly different from 9 d balances. However,
although our data suggest that complete faecal and urine
collection periods shorter than 9 d may be appropriate for
studies of Se retention, it is important to consider carefully
the collection time, in relation to factors such as
gastrointestinal passage time and dietary habits.
Although retention of the two inorganic forms of Se was
found to be similar, a large difference was observed in the
percentage absorption of SeO3
22 and SeO4
22; SeO4
22 was
almost completely absorbed (91 %) compared with 50 %
for SeO3
22. The between-subject variation in Se absorption
was larger for SeO3
22 (CV 15 %) than for SeO4
22 (CV
1·5 %), and confirmed previously reported data on inter-
individual variations in SeO3
22 absorption (Martin et al.
1989). A wide range of apparent Se absorption values (35–
85 %) based on stable-isotope techniques have been
reported for SeO3
22 (Janghorbani et al. 1982; Christensen
et al. 1983; Kasper et al. 1984; Sirichakwal et al. 1985;
Martin et al. 1989; Patterson et al. 1989; Mangels et al.
1990; Ducros et al. 1991; Finley, 1999). SeO3
22 has been
reported to interact with the lumen content, and therefore it
is likely that dietary habits influence Se absorption from
SeO3
22 (Vendeland et al. 1992). Martin et al. (1989)
reported that the percentage SeO3
22 absorption in adults
fed a Se-restricted diet (18 mg Se/d) was significantly
higher than that of a group fed 118 mg Se/d (89 v. 58
respectively). Recently, Finley (1999) also reported sig-
nificant differences in percentage SeO3
22 absorption
between subjects at low (32·6 mg Se/d) and high
(226·5 mg Se/d) Se intake, but contrary to the data of
Martin et al. (1989), higher mean Se absorption (38 % v.
15 %) was reported at the higher Se intake. As in the
present study, Thomson & Robinson (1986) found high Se
absorption from SeO4
22 (94 (SD 4) %) based on the
classical balance technique. Finley (1999) reported Se
absorption from SeO4
22 in the range of 68–76 % based on
a stable isotope technique. Our absorption data and those of
Thomson & Robinson (1986) for both SeO4
22 and SeO3
22
were substantially higher than those reported by Finley
(1999). In agreement with the data in human subjects,
higher Se absorption from SeO4
22 v. SeO3
22 was also
reported in animals (Wolffram et al. 1985; Vendeland et al.
1992). In those studies SeO4
22 was shown to be rapidly
transported across the brush border by a carrier-mediated
mechanism, whereas SeO3
22 was absorbed by passive
diffusion and showed a strong tendency to bind to the brush
border.
Renal excretion is the major pathway for elimination of
absorbed Se (Oster & Prellwitz, 1990). In the present study
Se excretion from SeO4
22 was high; approximately half the
Se absorbed from SeO4
22 was re-excreted in urine
compared with only 20 % for Se absorbed from SeO3
22.
The urinary excretion of Se absorbed from SeO4
22 was also
very rapid; 87 % of the total urinary Se excretion was
recovered within 24 h of administration while 90 % of the
total Se excretion of SeO3
22 was completed after 3 d.
Thomson & Robinson (1986) found similar differences for
total urinary Se excretion and excretion kinetics between
SeO4
22 and SeO3
22 after administration of a single dose of
Se (1 mg). Previous stable-isotope data in adults reported
urinary excretion for SeO3
22 which was similar to our
findings (Martin et al. 1989). The rapid and high Se
excretion from SeO4
22 is probably related to its more rapid
absorption and metabolism compared with SeO3
22 (Thom-
son & Robinson, 1986).
As an alternative to inorganic Se, organic Se could be
considered for food fortification. Se retention from organic
Se compounds such as selenomethionine and Se-rich yeast
has been demonstrated to be high at about 80–90 %
(Mangels et al. 1990; Alfthan et al. 1991). Organic Se may
not only be incorporated into Se-specific proteins such as
GSH-Px and iodothyronine deiodinase but also non-
specifically into blood proteins such as albumin and Hb
due to homology between selenomethionine and methio-
nine. It has been shown that organic and inorganic Se
compounds are equally well utilised for incorporation into
GSH-Px but that organic Se gives higher plasma and
erythrocyte Se levels (Alfthan et al. 1991; Xia et al. 1992;
Thomson et al. 1993; Ne`ve, 1995). The metabolic
similarity between selenomethionine and methionine has
been suggested as the reason for Se toxicity at high Se
intakes (Whanger, 1998).
Se compounds used for fortification of foods for groups
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at risk of low Se intake, such as patients with chronic or
acute disease or infants, should ensure adequate absorption
and retention of Se. Thus, fortification of nutritional
products with SeO4
22 could be considered to be more
efficient than SeO3
22. Nevertheless, SeO4
22 may not be
the ideal fortificant for individuals with impaired renal
function or preterm infants with immature renal function,
since SeO4
22 might not be as efficiently excreted as in
healthy individuals. For patients with malabsorption
syndromes SeO4
22 may be the more appropriate fortifica-
tion compound, since Se absorption from SeO3
22 has been
shown to be markedly reduced in patients with short bowel
syndrome (20 %) compared with healthy adults (82 %;
Rannem et al. 1996). Finally, concern has been raised about
the potential pro-oxidative properties of SeO3
22 and its
lower stability compared with SeO4
22 when added to foods
(Smith et al. 1995; Tyrala et al. 1996). Although these
issues need to be further investigated, they are additional
factors potentially in favour of the use of SeO4
22 for Se
fortification of foods.
In conclusion, the results from the present study indicate
that SeO3
22 and SeO4
22, when administered within normal
dietary intake ranges, were equally well retained in healthy
men, although large differences in absorption and urinary
excretion were observed. Thus, the nutritional impact of
foods fortified with either of these inorganic Se compounds
can be assumed to be similar in healthy individuals, at least
at the level of Se intake evaluated in the present study.
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